SCOPUS 정보 검색 플랫폼

Journal of Clinical Psychopharmacology

Volumn 31, Issue 2, 2011, Pages 245-246

Paliperidone augmentation for treatment-resistant depression: A case report

(2) Yang, Fei Wen a Liang, Chih Sung a

a Beitou Armed Forces Hospital (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLONAZEPAM; MIRTAZAPINE; PALIPERIDONE; QUETIAPINE; VENLAFAXINE; ZOLPIDEM;

ADULT; CASE REPORT; DIZZINESS; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; INSOMNIA; LABORATORY TEST; LETTER; MAJOR DEPRESSION; PHYSICAL EXAMINATION; POLLAKISURIA; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; REMISSION; SEDATION; SIDE EFFECT; SOCIAL PSYCHOLOGY; SUICIDAL IDEATION; THERAPY RESISTANCE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; XEROSTOMIA;

CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISOXAZOLES; MIDDLE AGED; PYRIMIDINES; TREATMENT OUTCOME;

EID: 79952436391 PISSN: 02710749 EISSN: None Source Type: Journal
DOI: 10.1097/JCP.0b013e31821083fb Document Type: Letter

Times cited : (4)

References (11)

1
- 34347345918
- Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: A meta-analysis
- Papakostas GI, Shelton RC, Smith J, et al. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis. J Clin Psychiatry. 2007;68:826-831. (Pubitemid 47015480)
- (2007) Journal of Clinical Psychiatry , vol.68 , Issue.6 , pp. 826-831
- Papakostas, G.I.¹ Shelton, R.C.² Smith, J.³ Fava, M.⁴

2
- 69949087539
- Atypical antipsychotic augmentation in major depressive disorder: A meta-analysis of placebo-controlled randomized trials
- Nelson JC, Papakostas GI. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry. 2009;166:980-991.
- (2009) Am J Psychiatry , vol.166 , pp. 980-991
- Nelson, J.C.¹ Papakostas, G.I.²

3
- 72949151592
- A rating scale for depression
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23: 56-62.
- (1960) J Neurol Neurosurg Psychiatry , vol.23 , pp. 56-62
- Hamilton, M.¹

4
- 34748864737
- The pipeline and future of drug development in schizophrenia
- DOI 10.1038/sj.mp.4002062, PII 4002062
- Gray JA, Roth BL. The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007;12:904-922. (Pubitemid 47482704)
- (2007) Molecular Psychiatry , vol.12 , Issue.10 , pp. 904-922
- Gray, J.A.¹ Roth, B.L.²

5
- 29344438343
- Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety
- Blier P, Szabo ST. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety. J Clin Psychiatry. 2005;66(suppl 8):30-40. (Pubitemid 43004173)
- (2005) Journal of Clinical Psychiatry , vol.66 , Issue.SUPPL. 8 , pp. 30-40
- Blier, P.¹ Szabo, S.T.²

6
- 70349564337
- The 5-HT7 receptor and disorders of the nervous system: An overview
- Hedlund PB. The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl). 2009;206: 345-354.
- (2009) Psychopharmacology (Berl) , vol.206 , pp. 345-354
- Hedlund, P.B.¹

7
- 33947676942
- 7, neurogenesis and antidepressants: A promising therapeutic axis for treating depression
- DOI 10.1111/j.1440-1681.2007.04608.x
- Nandam LS, Jhaveri D, Bartlett P. 5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression. Clin Exp Pharmacol Physiol. 2007;34:546-551. (Pubitemid 46494483)
- (2007) Clinical and Experimental Pharmacology and Physiology , vol.34 , Issue.5-6 , pp. 546-551
- Nandam, L.S.¹ Jhaveri, D.² Bartlett, P.³

8
- 67649452096
- Amisulpride is a potent 5-HT7 antagonist: Relevance for antidepressant actions in vivo
- Abbas AI, Hedlund PB, Huang XP, et al. Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology (Berl). 2009;205: 119-128.
- (2009) Psychopharmacology (Berl) , vol.205 , pp. 119-128
- Abbas, A.I.¹ Hedlund, P.B.² Huang, X.P.³

9
- 0042887023
- Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
- DOI 10.1038/sj.npp.1300203
- Shapiro DA, Renock S, Arrington E, et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology. 2003;28: 1400-1411. (Pubitemid 41070874)
- (2003) Neuropsychopharmacology , vol.28 , Issue.8 , pp. 1400-1411
- Shapiro, D.A.¹ Renock, S.² Arrington, E.³ Chiodo, L.A.⁴ Liu, L.-X.⁵ Sibley, D.R.⁶ Roth, B.L.⁷ Mailman, R.⁸

10
- 51749097254
- Antidepressants
- 3rd ed. New York, NY: Cambridge University Press
- Stahl SM. Antidepressants. In: Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 3rd ed. New York, NY: Cambridge University Press; 2008:558-561.
- (2008) Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications , pp. 558-561
- Stahl, S.M.¹

11
- 35048840777
- Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test
- DOI 10.1159/000104877
- Dhir A, Kulkarni SK. Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test. Pharmacology. 2007;80:239-243. (Pubitemid 47557257)
- (2007) Pharmacology , vol.80 , Issue.4 , pp. 239-243
- Dhir, A.¹ Kulkarni, S.K.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.